CMR316
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Calibr, a division of Scripps Research
Overview
CMR316 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
CMR316 clinical trials
Explore related
Medical disclaimer. This page summarizes research about CMR316 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.